Stereotaxis to Report Fourth Quarter and Full Year 2022 Financial Results on March 3, 2023

Rhea-AI Summary

Stereotaxis (NYSE: STXS), a leader in surgical robotics for minimally invasive endovascular interventions, plans to release its financial results for Q4 and the full year 2022 on March 3, 2023, before U.S. market opening. A conference call will occur at 10 a.m. EST to discuss these results and corporate developments. Investors can participate via the dial-in number 800-715-9871 (U.S. and Canada) or 1-646-307-1963 (International) with passcode 6529896. The webcast will also be available on Stereotaxis' investor relations site. This event is crucial for assessing the company's performance and future outlook following its successful applications in over 100,000 procedures globally.

Positive

• Innovative leader in surgical robotics with a significant global presence.
• Technology has been used in over 100,000 patient treatments, indicating strong market acceptance.

Negative

• None.

ST. LOUIS, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2022 fourth quarter and full year ended December 31, 2022 on Friday, March 3, 2023 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10 a.m. EST that day to discuss the Company’s results and corporate developments.

What:	Stereotaxis fourth quarter and full year 2022 financial results conference call
When:	Friday, March 3, 2023, at 10:00 a.m. EST (7:00 a.m. PST)
Dial In Number:	To access the live call, dial 800-715-9871 (US and Canada) or 1-646-307-1963 (International) and give the participant pass code 6529896.
Webcast:	To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at http://ir.stereotaxis.com/.
Call Replay:	A phone replay of the call will be available for one month beginning approximately four hours following the end of the call. To request access for a replay of the conference call, please click here.

About Stereotaxis
Stereotaxis (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat over 100,000 patients across the United States, Europe, Asia, and elsewhere. For more information, please visit www.stereotaxis.com.

Investor Contacts:                                        
David L. Fischel                                        
Chairman and Chief Executive Officer                        
                                                        
Kimberly Peery                                                
Chief Financial Officer

314-678-6100
Investors@Stereotaxis.com 

FAQ

When is Stereotaxis releasing its Q4 2022 financial results?

Stereotaxis will release its Q4 and full year 2022 financial results on March 3, 2023, before the U.S. market opens.

What time is the Stereotaxis conference call on March 3, 2023?

The conference call will be held at 10 a.m. EST on March 3, 2023.

How can I access the Stereotaxis conference call?

You can access the Stereotaxis conference call by dialing 800-715-9871 (U.S. and Canada) or 1-646-307-1963 (International) and using passcode 6529896.

Where can I find the webcast for the Stereotaxis financial results?

The webcast for Stereotaxis' financial results can be found on their investor relations website.